Cancer has claimed billions of life on earth. It is one of the deadliest diseases that mankind has faced since prehistory, and up until now, a cure is yet to be discovered. Scientists from all over the world are doing their best order to eradicate the disease, and they are publishing their works on different platforms, and one of it is Oncotarget. Oncotarget is a publication that is being released weekly, and scientists coming from the same field of oncology are the ones reviewing the articles that are being included in the journal. It tackles everything about oncology present status, the development on cure, and other information relating to cancer. The journal was first released in 2010, and it is published through Impact Journals. The journal’s editors in chief are both coming from the Roswell Park Cancer Institute – Andrei V. Gudkov, and Dr. Mikhail Blagosklonny.
2. Mikhail Blagosklonny is known for his quest to discover the key for immortality by researching about rapamycin. This research was first made known to the scientific world through Oncotarget, and its publication helped get the attention of his fellow scientists, shifting their attention to this ongoing study. Other oncologists are also posting their discoveries, researches and studies on the journal, and it is being updated regularly to reflect these new entries. One of the most recent entries being published in the journal is the research coming from the Norris Cotton Cancer Center in Dartmouth about a new strategy that would kill cancer cells while sparing the normal, healthy ones. According to their study, cells which could mutate into a tumor can be detected and be differentiated from a normal cell, and by identifying them, they can be selected and eradicated.
Reading the journal would give its readers high hopes about sacrifice and the dedication that the oncologists are pouring into their profession. Oncotarget has been a tool for scientists to openly share their knowledge with their peers, showing their progress in the battle against cancer. With publications like Oncotarget, these scientists could speed up the discovery of the cure for cancer.
To know more visit @: www.tandfonline.com/doi/pdf/10.4161/cbt.8.9.8899